These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 34582973)
1. Naloxone-reversible antidepressant-like effect of carbamazepine in mice: Without tolerance and withdrawal syndrome. Ghorbanzadeh B; Moradi S; Dousti F Neurosci Lett; 2021 Nov; 765():136272. PubMed ID: 34582973 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological evidence for the involvement of the opioid system in the antidepressant-like effect of simvastatin in mice: Without tolerance and withdrawal syndrome. Dolatshahi M; Davoudi S; Paridar Y; Naserzadeh R; Ghorbanzadeh B Neurosci Lett; 2020 Jan; 714():134578. PubMed ID: 31669314 [TBL] [Abstract][Full Text] [Related]
3. Low doses of acetaminophen produce antidepressive-like effects through the opioid system in mice. Ghorbanzadeh B; Azizolahi B; Masoudipur F; Boroun A; Azizi M; Oroojan AA; Jafrasteh S Behav Brain Res; 2024 Jul; 469():115065. PubMed ID: 38782097 [TBL] [Abstract][Full Text] [Related]
4. Opioid system contribution to the antidepressant-like action of m-trifluoromethyl-diphenyl diselenide in mice: A compound devoid of tolerance and withdrawal syndrome. Rosa SG; Pesarico AP; Tagliapietra CF; da Luz SC; Nogueira CW J Psychopharmacol; 2017 Sep; 31(9):1250-1262. PubMed ID: 28857657 [TBL] [Abstract][Full Text] [Related]
5. Evidence for the involvement of the opioid system in the antidepressant-like effect of folic acid in the mouse forced swimming test. Brocardo PS; Budni J; Lobato KR; Santos AR; Rodrigues AL Behav Brain Res; 2009 Jun; 200(1):122-7. PubMed ID: 19162083 [TBL] [Abstract][Full Text] [Related]
6. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis. Alcaraz C; Vargas ML; Milanés MV Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296 [TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator. Singh P; Sharma B; Gupta S; Sharma BM Psychopharmacology (Berl); 2015 Jan; 232(2):465-75. PubMed ID: 25059539 [TBL] [Abstract][Full Text] [Related]
8. Quantitative evaluation of opioid withdrawal signs in rats repeatedly treated with morphine and injected with naloxone, in the absence or presence of the antiabstinence agent clonidine. Pinelli A; Trivulzio S J Pharmacol Toxicol Methods; 1997 Nov; 38(3):117-31. PubMed ID: 9523765 [TBL] [Abstract][Full Text] [Related]
9. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance. Manning BH; Mao J; Frenk H; Price DD; Mayer DJ Pain; 1996 Sep; 67(1):79-88. PubMed ID: 8895234 [TBL] [Abstract][Full Text] [Related]
10. Disulfiram attenuates morphine or methadone withdrawal syndrome in mice. de Cordé A; Krząścik P; Wolińska R; Kleczkowska P; Filip M; Bujalska-Zadrożny M Behav Pharmacol; 2018 Aug; 29(5):393-399. PubMed ID: 29462108 [TBL] [Abstract][Full Text] [Related]
11. Kappa-opioid receptors mediate the antidepressant-like activity of hesperidin in the mouse forced swimming test. Filho CB; Del Fabbro L; de Gomes MG; Goes AT; Souza LC; Boeira SP; Jesse CR Eur J Pharmacol; 2013 Jan; 698(1-3):286-91. PubMed ID: 23178563 [TBL] [Abstract][Full Text] [Related]
12. Functional interaction between purinergic system and opioid withdrawal: in vitro evidence. Capasso A; Gallo C Curr Drug Saf; 2009 May; 4(2):97-102. PubMed ID: 19442100 [TBL] [Abstract][Full Text] [Related]
13. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence. Liu J; Schulteis G Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289 [TBL] [Abstract][Full Text] [Related]
14. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice. Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958 [TBL] [Abstract][Full Text] [Related]
15. Modification of the development of acute opiate tolerance by increased dopamine receptor sensitivity. Martin JR; Takemori AE J Pharmacol Exp Ther; 1987 Apr; 241(1):48-55. PubMed ID: 3572795 [TBL] [Abstract][Full Text] [Related]
16. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice. Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302 [TBL] [Abstract][Full Text] [Related]
17. Anxiolytic-like effects of morphine and buprenorphine in the rat model of fear-potentiated startle: tolerance, cross-tolerance, and blockade by naloxone. Glover EM; Davis M Psychopharmacology (Berl); 2008 Jun; 198(2):167-80. PubMed ID: 18324390 [TBL] [Abstract][Full Text] [Related]
18. [Behavioural studies during the gestational-lactation period in morphine treated rats]. Sobor M; Timár J; Riba P; Király KP; Al-Khrasani M; Gyarmati Z; Fürst Z Neuropsychopharmacol Hung; 2013 Dec; 15(4):239-51. PubMed ID: 24380965 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological evidence for the involvement of the opioid system in the antidepressant-like effect of adenosine in the mouse forced swimming test. Kaster MP; Budni J; Santos AR; Rodrigues AL Eur J Pharmacol; 2007 Dec; 576(1-3):91-8. PubMed ID: 17868670 [TBL] [Abstract][Full Text] [Related]
20. Modification of the expression of naloxone-precipitated withdrawal signs in morphine-dependent mice by diabetes: possible involvement of protein kinase C. Ohsawa M; Kamei J Jpn J Pharmacol; 1999 Mar; 79(3):303-11. PubMed ID: 10230858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]